Viatris Inc Quick Ratio (VTRS) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Viatris Inc   (NASDAQ: VTRS)

Viatris Inc 's Quick Ratio

VTRS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2026, Quick Ratio deteriorated to 0.22 below Viatris Inc 's average Quick Ratio.

Within Major Pharmaceutical Preparations industry 416 other companies have achieved higher Quick Ratio than Viatris Inc in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 3219, from total ranking in the first quarter 2026 at 4288.

Explain Quick Ratio?
How much Cash & cash equivalents VTRS´s has?
What are VTRS´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VTRS Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change -11.04 % 19.06 % 16.35 % -1.97 % -7.47 %
Y / Y Cash & cash equivalent Change 141.65 % 138.97 % 88.91 % -48.09 % -38.25 %
Quick Ratio MRQ 0.22 0.26 0.19 0.13 0.08
VTRS's Total Ranking # 3219 # 4288 # 4328 # 4716 # 4421
Seq. Current Liabilities Change -6.82 % -8.22 % 0.77 % 3.23 % 24.71 %
Seq. Cash & cash equivalent Change -24.14 % 29.98 % 42.33 % 72.19 % -24.98 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 417
Healthcare Sector # 817
Overall Market # 3327


Quick Ratio Statistics
High Average Low
2237.57 89.63 0.07
(Jun 28 2020)   (Jun 30 2021)




Financial Statements
Viatris Inc 's Current Liabilities $ 6,346 Millions Visit VTRS's Balance sheet
Viatris Inc 's Cash & cash equivalent $ 1,369 Millions Visit VTRS's Balance sheet
Source of VTRS's Sales Visit VTRS's Sales by Geography


Cumulative Viatris Inc 's Quick Ratio

VTRS's Quick Ratio for the trailling 12 Months

VTRS Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 4.48 % 5.16 % -5.86 % -13.66 % -11.23 %
Y / Y Cash & cash equivalent TTM Growth 40.7 % 10.46 % -18.93 % -36.88 % -7.05 %
Quick Ratio TTM 0.2 0.16 0.13 0.11 0.15
Total Ranking TTM # 2997 # 3644 # 2844 # 2764 # 2773
Seq. Current Liabilities TTM Growth -2.74 % 3.94 % 3.92 % -0.55 % -2.11 %
Seq. Cash & cash equivalent TTM Growth 16.95 % 28.47 % 21.55 % -22.96 % -8.19 %

Quick ratio ranking by company, industry and sector >> Back to VTRS Financial Strength Comparisons >> Go to Compare VTRS Quick Ratio to its Competitors

On the trailing twelve months basis VTRS Cash & cash equivalent more than doubled by 141.65 % in Q2 2026 year on year, while Current Liabilities decreased to $6,346 millions, this led to increase in in Viatris Inc 's Quick Ratio to 0.2, above VTRS average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 442 other companies have achieved higher Quick Ratio than Viatris Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 2944.

Explain Quick Ratio?
How much Cash & cash equivalents VTRS´s has?
What are VTRS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 443
Healthcare Sector # 909
Within the Market # 3219


trailing twelve months Quick Ratio Statistics
High Average Low
0.45 0.14 0.04
(Jun 30 2021)   (Mar 31 2021)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Bristol myers Squibb Company  0.59 $ 11,067.000  Millions$ 18,659.000  Millions
Prestige Consumer Healthcare Inc   0.58 $ 89.127  Millions$ 153.806  Millions
Biora Therapeutics Inc   0.57 $ 21.906  Millions$ 38.687  Millions
Matinas Biopharma Holdings Inc   0.56 $ 0.761  Millions$ 1.350  Millions
Karyopharm Therapeutics Inc   0.56 $ 75.225  Millions$ 134.233  Millions
Journey Medical Corp  0.56 $ 25.643  Millions$ 45.770  Millions
Nektar Therapeutics  0.55 $ 39.267  Millions$ 70.985  Millions
Supernus Pharmaceuticals inc   0.52 $ 180.145  Millions$ 347.378  Millions
Citius Oncology Inc  0.50 $ 16.564  Millions$ 33.152  Millions
Verrica Pharmaceuticals Inc   0.50 $ 11.198  Millions$ 22.442  Millions
Aytu Biopharma Inc  0.48 $ 26.308  Millions$ 54.659  Millions
Jupiter Neurosciences Inc   0.47 $ 1.522  Millions$ 3.251  Millions
Aeon Biopharma inc   0.47 $ 3.431  Millions$ 7.342  Millions
Evolus Inc   0.46 $ 45.170  Millions$ 98.731  Millions
Biomarin Pharmaceutical Inc  0.45 $ 874.005  Millions$ 1,927.164  Millions
Pds Biotechnology Corp  0.45 $ 5.596  Millions$ 12.377  Millions
Biofrontera Inc   0.44 $ 4.659  Millions$ 10.541  Millions
Beyondspring Inc   0.43 $ 10.361  Millions$ 23.834  Millions
Organon and Co   0.43 $ 1,132.000  Millions$ 2,616.000  Millions
Gossamer Bio Inc   0.41 $ 57.026  Millions$ 137.783  Millions
Bausch Health Companies Inc   0.39 $ 1,825.000  Millions$ 4,687.000  Millions
Johnson and Johnson  0.38 $ 21,094.000  Millions$ 54,895.000  Millions
Ultragenyx Pharmaceutical Inc   0.36 $ 125.000  Millions$ 351.000  Millions
Vanda Pharmaceuticals Inc   0.34 $ 56.119  Millions$ 164.026  Millions
Ainos Inc   0.29 $ 1.423  Millions$ 4.928  Millions
Elanco Animal Health Incorporated  0.29 $ 530.000  Millions$ 1,852.000  Millions
Provectus Biopharmaceuticals Inc   0.27 $ 1.157  Millions$ 4.234  Millions
Vireo Growth Inc.  0.27 $ 104.100  Millions$ 390.700  Millions
Phibro Animal Health Corporation  0.26 $ 81.994  Millions$ 316.468  Millions
Merck and Co Inc   0.26 $ 7,141.000  Millions$ 27,731.000  Millions

Date modified: 2026-09-12T06:24:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.